Insmed (INSM) PT Raised to $237 at Barclays

April 1, 2026 6:36 AM

Barclays analyst Eliana Merle raised the price target on Insmed (NASDAQ: INSM) to $237.00 (from $231.00) while maintaining a Overweight rating.

No results found